84 related articles for article (PubMed ID: 17560160)
21. Statin therapy alone and in combination with an acyl-CoA:cholesterol O-acyltransferase inhibitor on experimental atherosclerosis.
Worthley SG; Helft G; Corti R; Worthley MI; Chew DP; Fayad ZA; Zaman AG; Fallon JT; Fuster V; Badimon JJ
Pathophysiol Haemost Thromb; 2007; 36(1):9-17. PubMed ID: 18332609
[TBL] [Abstract][Full Text] [Related]
22. The neuropeptide pituitary adenylate cyclase activating polypeptide modulates Ca2+ and pro-inflammatory functions in human monocytes through the G protein-coupled receptors VPAC-1 and formyl peptide receptor-like 1.
El Zein N; Badran B; Sariban E
Cell Calcium; 2008 Mar; 43(3):270-84. PubMed ID: 17651798
[TBL] [Abstract][Full Text] [Related]
23. Suppression of inflammatory signaling in monocytes from patients with coronary artery disease.
Schirmer SH; Fledderus JO; van der Laan AM; van der Pouw-Kraan TC; Moerland PD; Volger OL; Baggen JM; Böhm M; Piek JJ; Horrevoets AJ; van Royen N
J Mol Cell Cardiol; 2009 Feb; 46(2):177-85. PubMed ID: 19059264
[TBL] [Abstract][Full Text] [Related]
24. 7beta-Hydroxycholesterol and 25-hydroxycholesterol-induced interleukin-8 secretion involves a calcium-dependent activation of c-fos via the ERK1/2 signaling pathway in THP-1 cells: oxysterols-induced IL-8 secretion is calcium-dependent.
Lemaire-Ewing S; Berthier A; Royer MC; Logette E; Corcos L; Bouchot A; Monier S; Prunet C; Raveneau M; Rébé C; Desrumaux C; Lizard G; Néel D
Cell Biol Toxicol; 2009 Apr; 25(2):127-39. PubMed ID: 18317936
[TBL] [Abstract][Full Text] [Related]
25. Inhibitory effect of leptin on growth hormone secretion of GH3 cells: involvement of cell proliferation, apoptosis and intracellular free Ca2+.
Liu Y; Zhong Y; Pei J; Zhu Y; Hu Y; Chi S; Kaye AD
Cytokine; 2009 May; 46(2):245-50. PubMed ID: 19297186
[TBL] [Abstract][Full Text] [Related]
26. [Regulation of intracellular cholesterol synthesis in hypercholesterolemia by glucocorticoids].
Petrichenko IE; Fuki IV; Koshechkin VA; Shakhov IuA
Biokhimiia; 1991 Dec; 56(12):2159-64. PubMed ID: 1807404
[TBL] [Abstract][Full Text] [Related]
27. Simvastatin inhibits catecholamine secretion and synthesis induced by acetylcholine via blocking Na+ and Ca2+ influx in bovine adrenal medullary cells.
Matsuda T; Toyohira Y; Ueno S; Tsutsui M; Yanagihara N
J Pharmacol Exp Ther; 2008 Oct; 327(1):130-6. PubMed ID: 18593956
[TBL] [Abstract][Full Text] [Related]
28. Impact of salusin-alpha and -beta on human macrophage foam cell formation and coronary atherosclerosis.
Watanabe T; Nishio K; Kanome T; Matsuyama TA; Koba S; Sakai T; Sato K; Hongo S; Nose K; Ota H; Kobayashi Y; Katagiri T; Shichiri M; Miyazaki A
Circulation; 2008 Feb; 117(5):638-48. PubMed ID: 18212280
[TBL] [Abstract][Full Text] [Related]
29. Expression and function of Na+/Ca2+ exchangers 1 and 3 in human macrophages and monocytes.
Staiano RI; Granata F; Secondo A; Petraroli A; Loffredo S; Frattini A; Annunziato L; Marone G; Triggiani M
Eur J Immunol; 2009 May; 39(5):1405-18. PubMed ID: 19350557
[TBL] [Abstract][Full Text] [Related]
30. Apolipoprotein C-I is crucially involved in lipopolysaccharide-induced atherosclerosis development in apolipoprotein E-knockout mice.
Westerterp M; Berbée JF; Pires NM; van Mierlo GJ; Kleemann R; Romijn JA; Havekes LM; Rensen PC
Circulation; 2007 Nov; 116(19):2173-81. PubMed ID: 17967778
[TBL] [Abstract][Full Text] [Related]
31. Hypercoagulability inhibits monocyte transendothelial migration through protease-activated receptor-1-, phospholipase-Cbeta-, phosphoinositide 3-kinase-, and nitric oxide-dependent signaling in monocytes and promotes plaque stability.
Seehaus S; Shahzad K; Kashif M; Vinnikov IA; Schiller M; Wang H; Madhusudhan T; Eckstein V; Bierhaus A; Bea F; Blessing E; Weiler H; Frommhold D; Nawroth PP; Isermann B
Circulation; 2009 Sep; 120(9):774-84. PubMed ID: 19687358
[TBL] [Abstract][Full Text] [Related]
32. Effect of rosuvastatin therapy on carotid plaque morphology and composition in moderately hypercholesterolemic patients: a high-resolution magnetic resonance imaging trial.
Underhill HR; Yuan C; Zhao XQ; Kraiss LW; Parker DL; Saam T; Chu B; Takaya N; Liu F; Polissar NL; Neradilek B; Raichlen JS; Cain VA; Waterton JC; Hamar W; Hatsukami TS
Am Heart J; 2008 Mar; 155(3):584.e1-8. PubMed ID: 18294500
[TBL] [Abstract][Full Text] [Related]
33. Systemic deficiency of the MAP kinase-activated protein kinase 2 reduces atherosclerosis in hypercholesterolemic mice.
Jagavelu K; Tietge UJ; Gaestel M; Drexler H; Schieffer B; Bavendiek U
Circ Res; 2007 Nov; 101(11):1104-12. PubMed ID: 17885219
[TBL] [Abstract][Full Text] [Related]
34. C-C chemokine receptor 2 expression by circulating monocytes influences atherosclerosis in patients on chronic hemodialysis.
Okumoto S; Taniguchi Y; Nakashima A; Masaki T; Ito T; Ogawa T; Takasugi N; Kohno N; Yorioka N
Ther Apher Dial; 2009 Jun; 13(3):205-12. PubMed ID: 19527467
[TBL] [Abstract][Full Text] [Related]
35. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
36. Role of the cholesterol biosynthetic pathway in osteoblastic differentiation.
Viccica G; Vignali E; Marcocci C
J Endocrinol Invest; 2007; 30(6 Suppl):8-12. PubMed ID: 17721067
[TBL] [Abstract][Full Text] [Related]
37. Impaired antiviral activity of monocytes from patients on hemodiafiltration.
Arena A; Coppolino G; Nostro L; Pavone B; Bonvissuto G; Campo S; Iannello D; Bonina L; Buemi M
J Nephrol; 2007; 20(5):560-7. PubMed ID: 17918141
[TBL] [Abstract][Full Text] [Related]
38. Simvastatin treatment in subjects at high cardiovascular risk modulates AT1R expression on circulating monocytes and T lymphocytes.
Marino F; Guasti L; Cosentino M; Rasini E; Ferrari M; Maio RC; Loraschi A; Cimpanelli MG; Schembri L; Legnaro M; Molteni E; Crespi C; Crema F; Venco A; Lecchini S
J Hypertens; 2008 Jun; 26(6):1147-55. PubMed ID: 18475152
[TBL] [Abstract][Full Text] [Related]
39. The long-term effect of angiotensin II type 1a receptor deficiency on hypercholesterolemia-induced atherosclerosis.
Eto H; Miyata M; Shirasawa T; Akasaki Y; Hamada N; Nagaki A; Orihara K; Biro S; Tei C
Hypertens Res; 2008 Aug; 31(8):1631-42. PubMed ID: 18971539
[TBL] [Abstract][Full Text] [Related]
40. Omega-3 as well as caloric restriction prevent the age-related modifications of cholesterol metabolism.
Martini C; Pallottini V; De Marinis E; Marino M; Cavallini G; Donati A; Straniero S; Trentalance A
Mech Ageing Dev; 2008 Dec; 129(12):722-7. PubMed ID: 18930075
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
